A Clinical Pharmacy Service to Prevent Drug-Drug Interactions and Potentially Inappropriate Medication: A Consecutive Intervention Study in Older Intermediate Care Patients of a Regional Hospital.

IF 2 Q3 PHARMACOLOGY & PHARMACY
Pharmacy Pub Date : 2025-04-24 DOI:10.3390/pharmacy13030060
Alexander Kilian Ullmann, Oliver Bach, Kathrin Mosch, Thilo Bertsche
{"title":"A Clinical Pharmacy Service to Prevent Drug-Drug Interactions and Potentially Inappropriate Medication: A Consecutive Intervention Study in Older Intermediate Care Patients of a Regional Hospital.","authors":"Alexander Kilian Ullmann, Oliver Bach, Kathrin Mosch, Thilo Bertsche","doi":"10.3390/pharmacy13030060","DOIUrl":null,"url":null,"abstract":"<p><p><i>Background:</i> In intermediate care, older patients with polypharmacy are vulnerable to drug-drug interactions (DDI) and potentially inappropriate medication (PIM). Aims: To perform a consecutive intervention study to evaluate DDI/PIM. <i>Methods:</i> Clinically-relevant DDI/PIM were identified using AMeLI (electronic medication list) and PRISCUS 2.0 (PIM list). Consecutive patients (standard care group) were screened for DDI/PIM after admission (t0) and again before discharge (t1). In an interim period, physicians received general education about DDI/PIM. Then, consecutive patients (independent clinical pharmacy group) were screened for DDI/PIM after admission (t2). Physicians were then provided with patient-individualized recommendations by a clinical pharmacist to prevent DDI/PIM. The patients were then screened again for DDI/PIM before discharge (t3). <i>Results:</i> In each group, 100 patients were included with data available for evaluation from 97 (standard care group, median age: 78 years [Q25/Q75: 69/84]) and 89 (clinical pharmacy group, 76 years [67/84]). In the standard care group, DDI were identified in 55 (57%) patients after admission (t0) and 54 (56%) before discharge (t1, ARR[t0/t1] = 0.01, NNT[t0/t1] = 100, n.s.). In the clinical pharmacy group, DDI were identified in 32 (36%) after admission (t2; ARR[t0/t2] = 0.21/NNT[t0/t2] = 5, <i>p</i> < 0.01) and 26 (29%) before discharge (t3; ARR[t2/t3] = 0.07/NNT[t2/t3] = 15, n.s.; ARR[t1/t3] = 0.27/NNT[t1/t3] = 4, <i>p</i> < 0.001). PIM were identified in patients at t0: 34 (35%), t1: 35 (36%, ARR[t0/t1] = -0.01/NNH[t0/t1] = 100, n.s.), t2: 25 (26%, ARR[t0/t2] = 0.09/NNT[t0/t2] = 12, n.s.), t3: 23 (24%, ARR[t2/t3] = 0.11/NNT[t2/t3] = 10, n.s.; ARR[t1/t3] = 0.12/NNT[t1/t3] = 9, n.s.). <i>Conclusions:</i> In the standard care group, after admission, many DDI/PIM were identified in older intermediate care patients. Before discharge, their number was hardly influenced at all. General education for physicians led to DDI prevention after admission. In addition, the DDI frequency decreased by providing physicians with patient-individualized recommendations.</p>","PeriodicalId":30544,"journal":{"name":"Pharmacy","volume":"13 3","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12101412/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/pharmacy13030060","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: In intermediate care, older patients with polypharmacy are vulnerable to drug-drug interactions (DDI) and potentially inappropriate medication (PIM). Aims: To perform a consecutive intervention study to evaluate DDI/PIM. Methods: Clinically-relevant DDI/PIM were identified using AMeLI (electronic medication list) and PRISCUS 2.0 (PIM list). Consecutive patients (standard care group) were screened for DDI/PIM after admission (t0) and again before discharge (t1). In an interim period, physicians received general education about DDI/PIM. Then, consecutive patients (independent clinical pharmacy group) were screened for DDI/PIM after admission (t2). Physicians were then provided with patient-individualized recommendations by a clinical pharmacist to prevent DDI/PIM. The patients were then screened again for DDI/PIM before discharge (t3). Results: In each group, 100 patients were included with data available for evaluation from 97 (standard care group, median age: 78 years [Q25/Q75: 69/84]) and 89 (clinical pharmacy group, 76 years [67/84]). In the standard care group, DDI were identified in 55 (57%) patients after admission (t0) and 54 (56%) before discharge (t1, ARR[t0/t1] = 0.01, NNT[t0/t1] = 100, n.s.). In the clinical pharmacy group, DDI were identified in 32 (36%) after admission (t2; ARR[t0/t2] = 0.21/NNT[t0/t2] = 5, p < 0.01) and 26 (29%) before discharge (t3; ARR[t2/t3] = 0.07/NNT[t2/t3] = 15, n.s.; ARR[t1/t3] = 0.27/NNT[t1/t3] = 4, p < 0.001). PIM were identified in patients at t0: 34 (35%), t1: 35 (36%, ARR[t0/t1] = -0.01/NNH[t0/t1] = 100, n.s.), t2: 25 (26%, ARR[t0/t2] = 0.09/NNT[t0/t2] = 12, n.s.), t3: 23 (24%, ARR[t2/t3] = 0.11/NNT[t2/t3] = 10, n.s.; ARR[t1/t3] = 0.12/NNT[t1/t3] = 9, n.s.). Conclusions: In the standard care group, after admission, many DDI/PIM were identified in older intermediate care patients. Before discharge, their number was hardly influenced at all. General education for physicians led to DDI prevention after admission. In addition, the DDI frequency decreased by providing physicians with patient-individualized recommendations.

预防药物相互作用和潜在不适当用药的临床药学服务:对某地区医院中老年护理患者的连续干预研究
背景:在中间护理中,老年多药患者容易发生药物相互作用(DDI)和潜在的不适当用药(PIM)。目的:通过一项连续干预研究来评估DDI/PIM。方法:采用AMeLI(电子用药清单)和PRISCUS 2.0 (PIM清单)对临床相关DDI/PIM进行鉴定。连续患者(标准治疗组)在入院后(t0)和出院前(t1)再次进行DDI/PIM筛查。在此期间,医生接受了关于DDI/PIM的普通教育。然后,连续患者(独立临床药学组)在入院后(t2)进行DDI/PIM筛查。然后,临床药剂师向医生提供患者个性化的建议,以预防DDI/PIM。出院前(t3)再次对患者进行DDI/PIM筛查。结果:每组纳入100例患者,可用于评估的资料来自97例(标准治疗组,中位年龄:78岁[Q25/Q75: 69/84])和89例(临床药学组,76岁[67/84])。标准治疗组患者入院后(t0)和出院前(t1, ARR[t0/t1] = 0.01, NNT[t0/t1] = 100, n.s)分别有55例(57%)和54例(56%)出现DDI。临床药学组入院后发现DDI 32例(36%)(t2;出院前ARR[t0/t2] = 0.21/NNT[t0/t2] = 5, p < 0.01), 26 (29%);ARR[t2/t3] = 0.07/NNT[t2/t3] = 15, n.s;ARR[t1/t3] = 0.27/NNT[t1/t3] = 4, p < 0.001)。PIM在t0: 34 (35%), t1: 35 (36%), ARR[t0/t1] = -0.01/NNH[t0/t1] = 100 (n例),t2: 25 (26%, ARR[t0/t2] = 0.09/NNT[t0/t2] = 12, n例),t3: 23 (24%, ARR[t2/t3] = 0.11/NNT[t2/t3] = 10, n例;ARR[t1/t3] = 0.12/NNT[t1/t3] = 9, n.s。结论:在标准护理组,入院后,许多老年中间护理患者中发现了DDI/PIM。出院前,其数量几乎不受影响。对医生进行通识教育有助于预防入院后的DDI。此外,通过向医生提供患者个性化的建议,DDI频率降低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmacy
Pharmacy PHARMACOLOGY & PHARMACY-
自引率
9.10%
发文量
141
审稿时长
11 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信